Concepedia

Cunshan Wang

CW

Statistics

Publications

60

Citations

5.6K

H-Index

33

Active since

2003

Affiliations

Pfizer (United States)(Current)

Dalian University of Technology

Pfizer (Canada)

Toronto Western Hospital

Swedish Medical Center

Cunshan Wang is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Publications per year

2003–2025

60

Publications

60

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg, Deepak L. Bhatt, Ted R. Mikuls et al. · New England Journal of Medicine · 2022 · 1.7K citations · Full text

, , +15

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis

Philip J. Mease, Stephen Hall, Oliver FitzGerald et al. · New England Journal of Medicine · 2017 · 560 citations

, , +14

Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors

Dafna D. Gladman, William F. C. Rigby, Valderílio Feijó Azevedo et al. · New England Journal of Medicine · 2017 · 508 citations · Full text

, , +14

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

Atul Deodhar, Paula Śliwińska-Stańczyk, Huji Xu et al. · Annals of the Rheumatic Diseases · 2021 · 248 citations · Full text

, , +10

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

Philip J. Mease, Christina Charles‐Schoeman, Stanley Cohen et al. · Annals of the Rheumatic Diseases · 2020 · 221 citations · Full text

, , +17

1–5 of 60